Cite

HARVARD Citation

    Bando, H. et al. (2016). A multicenter phase II study of TAS-102 monotherapy in patients with pre-treated advanced gastric cancer (EPOC1201). European journal of cancer. pp. 46-53. [Online]. 
  
Back to record